NPI registry status
Active
2026 NPPES data Pediatric Dermatology Physician NPI 1467416768 MD
Verify on CMS → Michael Bobrow, MD
Pediatric Dermatology Physician in Rochester, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 238 in Pediatric Dermatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 639 beneficiaries · Pediatric Dermatology Physician avg: 553
Generic prescribing
90%
generic claims · 10% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$963.48
60 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Michael Bobrow, MD filed 1,390 Medicare Part D claims in 2024 as a Pediatric Dermatology Physician in Rochester, New York, prescribing 90% generic.
- 1K
- Part D claims, 2024
- 90%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥79th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Michael Bobrow, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1467416768), first enumerated 04/13/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,390 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$963.48 in reported industry payments (60 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
New York statewide board action statistics are published annually — these figures describe aggregate state activity, not Michael Bobrow, MD's individual license status. Verify directly with the state medical board.
Source: NYSBPMC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1467416768 · Pediatric Dermatology Physician
NPI-10 · ENUM-LEGACY · TAX-TRACE · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1467416768
- ENUM-LEGACY 2006
- TAX-TRACE 238
- RX-MID 1,390
- BOOK-THIN 15 in New York
- PHOTO-ENUM Hanspaul Makkar, MD · 2006
Michael Bobrow, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
1,390 ≥ 79th percentile 79% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Michael Bobrow, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Michael Bobrow, MD?
Quality data not reportedPrimary specialty
Pediatric Dermatology Physician
Medicare Part D claims
1,390 151% vs specialty avg
Specialty distribution in New York
How Pediatric Dermatology Physician compares to other specialties among New York providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pediatric Dermatology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1467416768 |
|---|---|
| Specialty | Pediatric Dermatology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 04/13/2006 |
Hospital and facility affiliations
Facilities where Michael Bobrow, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Greece Dermatological Associates PC
Rochester, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Michael Bobrow, MD. Source: openpaymentsdata.cms.gov.
Total received
$963
Largest payer
UCB, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Michael Bobrow, MD. To verify Michael Bobrow, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Michael Bobrow, MD - brand share 10.0%
Pediatric Dermatology Physician average
10% brand-name claims vs 90% generic, on 1,390 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,390
Total Claims
$884K
Total Drug Cost
639
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,693.133
- Total Day Supply
- 44,862
- Brand vs Generic
- 10% brand / 90% generic
- Brand Drug Cost
- $835K
- Generic Drug Cost
- $49K
- Antibiotic Claims
- 100
Patient Demographics
- Average Patient Age
- 74.9 years
- Avg HCC Risk Score
- 0.93
- Gender Split
- 40% female / 60% male
- Age Distribution
- <65: 28, 65-74: 294, 75-84: 240, 85+: 77
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Michael Bobrow, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Clobetasol Propion…
Clobetasol Propionate
176 claims
- Econazole Nitrate
Econazole Nitrate
128 claims
- Fluocinonide
Fluocinonide
125 claims
- Metronidazole
Metronidazole
82 claims
- Valacyclovir 68
Valacyclovir
68 claims
- Desonide 66
Desonide
66 claims
- Tacrolimus 62
Tacrolimus
62 claims
- Mupirocin 51
Mupirocin
51 claims
| Drug | Claims |
|---|---|
| Clobetasol Propionate | 176 |
| Econazole Nitrate | 128 |
| Fluocinonide | 125 |
| Metronidazole | 82 |
| Valacyclovir Valacyclovir Hcl | 68 |
| Desonide | 66 |
| Tacrolimus | 62 |
| Mupirocin | 51 |
| Triamcinolone Acetonide | 50 |
| Alclometasone Dipropionate | 42 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pediatric Dermatology Physician Overview
How Michael Bobrow, MD fits within the Pediatric Dermatology Physician landscape nationally.
238
Pediatric Dermatology Physician Providers in US
41
States with Pediatric Dermatology Physician
553
Avg Claims per Provider
Michael Bobrow, MD's 1,390 claims are above the specialty average of 553.
Nationwide Pediatric Dermatology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Bobrow, both outside New York so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pediatric Dermatology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Bobrow.
One of 15 Pediatric Dermatology Physician providers enrolled in New York, 5 are shown here.
Dr. Anna Bender-Zeckendorf
M.D.
New York, NY
Dr. Karen Chernoff
M.D.
New York, NY
Dr. Jinia El Feghaly
MD
Rochester, NY
Dr. Julia Gittler
MD
Bronx, NY
Dr. Sharon Glick
M.D.
Brooklyn, NY
Compare Pediatric Dermatology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Michael Bobrow, MD's specialty? ▼
Michael Bobrow, MD specializes in Pediatric Dermatology Physician and practices in Rochester, New York. Credentials: MD.
How much does Michael Bobrow, MD prescribe under Medicare Part D? ▼
In 2024, Michael Bobrow, MD wrote 1,390 Medicare Part D claims totaling $884K in drug costs for 639 beneficiaries.
Where is Michael Bobrow, MD located? ▼
Michael Bobrow, MD is located at 120 ERIE CANAL DR STE 200, Rochester, NY, 14626. Phone: (585) 719-9600.
What is Michael Bobrow, MD's NPI number? ▼
Michael Bobrow, MD's National Provider Identifier (NPI) is 1467416768, issued on 04/13/2006.
Does Michael Bobrow, MD prescribe more brand-name or generic drugs? ▼
Michael Bobrow, MD's prescribing is 10% brand-name and 90% generic drugs by claim count, with $835K in brand drug costs.
How many Pediatric Dermatology Physician providers are there in the US? ▼
There are 238 Pediatric Dermatology Physician providers across 41 states in the US. The average Pediatric Dermatology Physician provider writes 553 Medicare Part D claims per year.
What drugs does Michael Bobrow, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Michael Bobrow, MD's most frequently prescribed drugs include Clobetasol Propionate, Econazole Nitrate, Fluocinonide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Michael Bobrow, MD accept Medicare? ▼
Michael Bobrow, MD appears in CMS Medicare data with 1,390 Part D claims and 639 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Michael Bobrow, MD's credentials? ▼
Michael Bobrow, MD's NPI is 1467416768 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.